Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 10—October 2012

Multidrug-Resistant Salmonella enterica, Democratic Republic of the Congo

Marie-France Phoba1, Octavie Lunguya1, Daniel Vita Mayimon, Pantaléon Lewo di Mputu, Sophie Bertrand, Raymond Vanhoof, Jan Verhaegen, Chris Van Geet, Jean-Jacques Muyembe, and Jan JacobsComments to Author 
Author affiliations: National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo (M.-F. Phoba, O. Lunguya, J.-J. Muyembe); University Hospital of Kinshasa, Kinshasa (M.-F. Phoba, O. Lunguya, J.-J. Muyembe); Saint-Luc Hospital, Kisantu, Democratic Republic of the Congo (D.V. Mayimona, P. Lewo di Mputu); Institute of Public Health, Brussels, Belgium (S. Bertrand, R. Vanhoof); University Hospital Leuven, Leuven, Belgium (J. Verhaegen, C. Van Geet); and Institute of Tropical Medicine, Antwerp, Belgium (J. Jacobs)

Main Article


MICs and genetic analysis of Salmonella enterica isolates with decreased ciprofloxacin susceptibility, Democratic Rebublic of the Congo

Serotype MIC, mg/L
No. isolates Mutations
Nalidixic acid Ciprofloxacin
Enteritidis 128 0.094 1 Asp82-Asn in gyrA + qnrB
Typhimurium >256 0.125 1 Asp87-Tyr in gyrA + qnrB
Typhi >256 0.19–0.25 7 Ser83-Phe in gyrA

Main Article

1These authors contributed equally to this article.

Page created: September 19, 2012
Page updated: September 19, 2012
Page reviewed: September 19, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.